The emotional ear in stress

Neuroscience and Biobehavioral Reviews

Volumn 27, Issue 5, 2003, Pages 437-446

  Horner, K C ^a  

^a INSERM   (France)

Author keywords

Corticosteroids; Hearing; Hypothalamus pituitary adrenal axis; Stress; Tinnitus; Vertigo

Indexed keywords

ARGIPRESSIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTEROID; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; PROLACTIN; VASOPRESSIN;

AUDITORY NERVOUS SYSTEM; CORRELATION ANALYSIS; CORTICOTROPIN BLOOD LEVEL; EAR DISEASE; EAR PROTECTION; EMOTIONAL STRESS; HEARING LOSS; HORMONAL REGULATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MENTAL STRESS; NEUROENDOCRINOLOGY; NEUROMODULATION; NEUROPATHOLOGY; NORADRENERGIC SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; REVIEW; SYMPATHETIC TONE; TINNITUS; VASOPRESSIN BLOOD LEVEL; VERTIGO;

EID: 0141515415     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(03)00071-X     Document Type: Article

References (166)

1. Cannon W.B. The wisdom of the body. Physiol Rev. 9:1929;399-431.
2. Selye A. A syndrome produced by divers noxious agents. Nature. 138:1936;32-33.
3. Harris G.W. Neural control of the pituitary gland. 1955;Edward Arnold, London.
4. Piva F., Motta M., Martini L. Regulation of hypothalamic and pituitary function, long, short and ultrashort feedback loops. de Groot L. Endocrinology, vol. 1. 1979;21-33 Grune & Statton, New York.
5. McEwen B.S. Protective and damaging effects of stress mediators, the good and bad sides of the response to stress. Metabolism. 51:2002;2-4.
6. Seymour J.L., Tappin J.W. The effect of sympathetic nervous system in relation to the inner ear. Acta Otolaryngol. 42:1952;167-173.
7. Fowler E., Zeckel A. Psychosomatic aspects of ménière's disease. J Am Med Assoc. 148:1952;1265-1268.
8. Andersson G., Hagnebo C., Yardley L. Stress and symptoms of Meniere's disease, a time-series analysis. J Psychosom Res. 43:1997;595-603.
9. Yardley L., Owen N., Nazareth I., Luxon L. Prevalence and presentation of dizziness in a general practice community sample of working age people. Br J Gen Pract. 48:1998;1131-1135.
10. Yardley L., Burgneay J., Nazareth I., Luxon L. Neuro-otological and psychiatric abnormalities in a community sample of people with dizziness, a blind, controlled investigation. J Neurol Neurosurg Psychiatry. 65:1998;679-684.
11. Seemungal B.M., Gresty M.A., Bronstein A.M. The endocrine system, vertigo and balance. Curr Opin Neurol. 14:2001;27-34.
12. Madden K.S., Sanders V.M., Felten D.L. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol. 35:1995;417-448.
13. Turnbull A.V., Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines, actions and mechanisms of action. Physiol Rev. 79:1999;1-71.
14. Dorshkind K., Horseman N.D. Anterior pituitary hormones, stress, and immune system homeostasis. Bioessays. 23:2001;288-294.
15. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems, the brain and the immune system. Pharmacol Rev. 52:2000;595-638.
16. Webster J.I., Tonelli L., Sternberg E.M. Neuroendocrine regulation of immunity. Annu Rev Immunol. 20:2002;125-163.
17. McCabe B.F. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol. 88:1979;585-590.
18. Veldman J. Immune-mediated sensorineural hearing loss. Auris Nasus Larynx. 25:1998;309-317.
19. Ryan A.F., Pak K., Low W., Battaglia A., Mullen L., Harris J.P., Keithley E.M. Immunological damage to the inner ear, current and future therapeutic strategies. Adv Otorhinolaryngol. 59:2002;66-74.
20. Spoendlin H., Lichtensteiger W. The adrenergic innervation of the labyrinth. Acta Otolaryngol. 61:1966;423-434.
21. Spoendlin H., Lichtensteiger W. The sympathetic nerve supply to the inner ear. Arch Klin Exp Ohren Nasen Kehlkopfheilkd. 189:1967;346-359.
22. Ohlsen K.A., Baldwin D.L., Nuttall A.L., Miller J.M. Influence of topically applied adrenergic agents on cochlear blood flow. Circ Res. 69:1991;509-518.
23. Laurikainen E.A., Costa O., Miller J.M., Nuttall A.L., Ren T.Y., Masta R., Quirk W.S., Robinson P.J. Neuronal regulation of cochlear blood flow in the guinea-pig. J Physiol. 480:1994;563-573.
24. Gruber D.D., Dang H., Shimozono M., Scofield M.A., Wangemann P. Alpha1A-adrenergic receptors mediate vasoconstriction of the isolated spiral modiolar artery in vitro. Hear Res. 119:1998;113-124.
25. Birgersson L., Friberg U., Rask-Andersen H., Erwall C., Widenfalk B. Origin of sympathetic and sensory innervation of the endolymphatic sac. A retrograde axonal tracing study in the guinea pig. ORL J Otorhinolaryngol Relat Spec. 54:1992;188-190.
26. Hozawa K., Takasaka T. Sympathetic and CGRP-positive nerve supply to the endolymphatic sac of guinea pig. Acta Otolaryngol Suppl. 506:1993;14-17.
27. Rask-Andersen H., Stahle J. Immunodefence of the inner ear? Lymphocyte-macrophage interaction in the endolymphatic sac. Acta Otolaryngol. 89:1980;283-294.
28. Benschop R.J., Rodriguez-Feuerhahn M., Schedlowski M. Catecholamine-induced leukocytosis, early observations, current research, and future directions. Brain Behav Immun. 10:1996;77-91.
29. Muchnik C., Hildesheimer M., Rubinstein M. Effect of emotional stress on hearing. Arch Otorhinolaryngol. 228:1980;295-298.
30. Juhn S.K., Li W., Kim J.Y., Javel E., Levine S., Odland R.M. Effect of stress-related hormones on inner ear fluid homeostasis and function. Am J Otol. 20:1999;800-806.
31. Muchnik C., Rosenthal T., Peleg E., Hildesheimer M. Stress reaction to intense sound exposure under different arousal levels in guinea pigs. Acta Otolaryngol. 118:1998;646-650.
32. Giraudet F., Horner K.C., Cazals Y. Similar half-octave TTS protection of the cochlea by xylazine/ketamine or sympathectomy. Hear Res. 174:2002;239-248.
33. Gil-Loyzaga P., Vicente-Torres M.A., Arce A., Cardinali D.P., Esquifino A. Effect of superior cervical ganglionectomy on catecholamine concentration in rat cochlea. Brain Res. 779:1998;53-57.
34. Hultcrantz E., Nuttall A.L., Brown M.C., Lawrence M. The effect of cervical sympathectomy on cochlear electrophysiology. Acta Otolaryngol. 94:1982;439-444.
35. Borg E. Susceptibility of the sympathectomized ear to noise-induced hearing loss. Acta Physiol Scand. 114:1982;387-391.
36. Horner K.C., Giraudet F., Lucciano M., Cazals Y. Sympathectomy improves the ear's resistance to acoustic trauma - could stress render the ear more sensitive? Eur J Neurosci. 13:2001;405-408.
37. Pickles J.O. An investigation of sympathetic effects on hearing. Acta Otolaryngol. 87:1979;69-71.
38. Hildesheimer M., Henkin Y., Pye A., Heled S., Sahartov E., Shabtai E.L., Muchnik C. Bilateral superior cervical sympathectomy and noise-induced, permanent threshold shift in guinea pigs. Hear Res. 163:2002;46-52.
39. Comis S.D., Whitfield I.C. Influence of centrifugal pathways on unit activity in the cochlear nucleus. J Neurophysiol. 31:1968;62-68.
40. Anden N.E., Fuxe K., Larsson K. Effect of large mesencephalic-diencephalic lesions on the noradrenalin, dopamine and 5-hydroxytryptamine neurons of the central nervous system. Experientia. 22:1966;842-843.
41. Woods C.I., Azeredo W.J. Noradrenergic and serotonergic projections to the superior olive, potential for modulation of olivocochlear neurons. Brain Res. 836:1999;9-18.
42. Wynne B., Robertson D. Localization of dopamine-beta-hydroxylase-like immunoreactivity in the superior olivary complex of the rat. Audiol Neurootol. 1:1996;54-64.
43. Mulders W.H., Robertson D. Origin of the noradrenergic innervation of the superior olivary complex in the rat. J Chem Neuroanat. 21:2001;313-322.
44. Klepper A., Herbert H. Distribution and origin of noradrenergic and serotonergic fibers in the cochlear nucleus and inferior colliculus of the rat. Brain Res. 557:1991;190-201.
45. Pickles J.O. The noradrenaline-containing innervation of the cochlear nucleus and the detection of signals in noise. Brain Res. 105:1976;591-596.
46. Wang X., Robertson D. Two types of actions of norepinephrine on identified auditory efferent neurons in rat brain stem slices. J Neurophysiol. 78:1997;1800-1810.
47. Plotsky P.M., Sawchenko P.E. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy. Endocrinology. 120:1987;1361-1369.
48. Antoni F.A. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol. 14:1993;76-122.
49. de Kloet E.R. Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol. 12:1991;95-164.
50. Paulmyer-Lacroix O., Anglade G., Grino M. Insulin-induced hypoglycaemia increases colocalization of corticotrophin-releasing factor and arginine vasopressin mRNAs in the rat hypothalamic paraventricular nucleus. J Mol Endocrinol. 13:1994;313-320.
51. de Keyzer Y., Auzan C., Lenne F., Beldjord C., Thibonnier M., Bertagna X., Clauser E. Cloning and characterization of the human V3 pituitary vasopressin receptor. FEBS Lett. 356:1994;215-220.
52. Furuta H., Mori N., Sato C., Hoshikawa H., Sakai S., Iwakura S., Doi K. Mineralocorticoid type I receptor in the rat cochlea, mRNA identification by polymerase chain reaction (PCR) and in situ hybridization. Hear Res. 78:1994;175-180.
53. Rarey K.E., Luttge W.G. Presence of type I and type II/IB receptors for adrenocorticosteroid hormones in the inner ear. Hear Res. 41:1989;217-221.
54. Pitovski D.Z., Drescher M.J., Drescher D.G. High affinity aldosterone binding sites (type I receptors) in the mammalian inner ear. Hear Res. 69:1993;10-14.
55. Sinha P.K., Pitovski D.Z. [3H]-aldosterone binding sites (type I receptors) in the lateral wall of the cochlea, distribution assessment by quantitative autoradiography. Acta Otolaryngol. 115:1995;643-647.
56. Yao X., Rarey K.E. Localization of the mineralocorticoid receptor in rat cochlear tissue. Acta Otolaryngol. 116:1996;493-496.
57. Rarey K.E., Curtis L.M., ten Cate W.J. Tissue specific levels of glucocorticoid receptor within the rat inner ear. Hear Res. 64:1993;205-210.
58. ten Cate W.J., Curtis L.M., Small G.M., Rarey K.E. Localization of glucocorticoid receptors and glucocorticoid receptor mRNAs in the rat cochlea. Laryngoscope. 103:1993;865-871.
59. Pitovski D.Z., Drescher M.J., Drescher D.G. Glucocorticoid receptors in the mammalian inner ear, RU 28362 binding sites. Hear Res. 77:1994;216-220.
60. Zuo J., Curtis L.M., Yao X., ten Cate W.J., Bagger-Sjoback D., Hultcrantz M., Rarey K.E. Glucocorticoid receptor expression in the postnatal rat cochlea. Hear Res. 87:1995;220-227.
61. ten Cate W.J., Patterson K., Rarey K.E. Ultrastructure of ampullar dark cells in the absence of circulating adrenocorticosteroid hormones. Acta Otolaryngol. 110:1990;234-240.
62. Lohuis P.J., ten Cate W.J., Patterson K.E., Rarey K.E. Modulation of the rat stria vascularis in the absence of circulating adrenocorticosteroids. Acta Otolaryngol. 110:1990;348-356.
63. Rarey K.E., Lohuis P.J., ten Cate W.J. Response of the stria vascularis to corticosteroids. Laryngoscope. 101:1991;1081-1084.
64. Ma Y.L., Rarey K.E., Gerhardt K.J., Garg L.C., Rybak L.P. Altered calcium homeostasis in the rat cochlear duct and endogenous corticosteroid insufficiency. Eur Arch Otorhinolaryngol. 254:1997;165-168.
65. Ma Y.L., Rarey K.E., Gerhardt K.J., Curtis L.M., Rybak L.P. Electrochemical potentials and potassium concentration profiles recorded from perilymph, endolymph and associated inner ear tissues in adrenalectomized rats. Hear Res. 96:1996;151-156.
66. Rarey K.E., Tyneway D., Patterson K. Decreased adenosine triphosphatase activity in the absence of adrenocorticosteroids. Arch Otolaryngol Head Neck Surg. 115:1989;817-821.
67. Curtis L.M., Rarey K.E. Effect of stress on cochlear glucocorticoid protein. II. Restraint. Hear Res. 92:1995;120-125.
68. Zuo J., Curtis L.M., Yao X., Ten Cate W.J., Rarey K.E. Expression of Na, K-ATPase alpha and beta isoforms in the neonatal rat cochlea. Acta Otolaryngol. 115:1995;497-503.
69. Yao X., ten Cate W.J., Curtis L.M., Rarey K.E. Expression of Na+,K(+)-ATPase alpha 1 subunit mRNA in the developing rat cochlea. Hear Res. 80:1994;31-37.
70. Erichsen S., Zuo J., Curtis L., Rarey K., Hultcrantz M. Na,K-ATPase alpha- and beta-isoforms in the developing cochlea of the mouse. Hear Res. 100:1996;143-149.
71. Erichsen S., Stierna P., Bagger-Sjoback D., Curtis L.M., Rarey K.E., Schmid W., Hultcrantz M. Distribution of Na,K-ATPase is normal in the inner ear of a mouse with a null mutation of the glucocorticoid receptor. Hear Res. 124:1998;146-154.
72. Lohuis P.J., Borjesson P.K., Klis S.F., Smoorenburg G.F. The rat cochlea in the absence of circulating adrenal hormones, an electrophysiological and morphological study. Hear Res. 143:2000;189-196.
73. Ma Y.L., Gerhardt K.J., Curtis L.M., Rybak L.P., Whitworth C., Rarey K.E. Combined effects of adrenalectomy and noise exposure on compound action potentials, endocochlear potentials and endolymphatic potassium concentrations. Hear Res. 91:1995;79-86.
74. Wang Y., Liberman M.C. Restraint stress and protection from acoustic injury in mice. Hear Res. 165:2002;96-102.
75. Rarey K.E., Gerhardt K.J., Curtis L.M., ten Cate W.J. Effect of stress on cochlear glucocorticoid protein, acoustic stress. Hear Res. 82:1995;135-138.
76. Alario P., Gamallo A., Villanua M.A., Trancho G. Chronic noise stress and dexamethasone administration on blood pressure elevation in the rat. J Steroid Biochem. 28:1987;433-436.
77. Vicente-Torres M.A., Gil-Loyzaga P. Noise stimulation decreases the concentration of norepinephrine in the rat cochlea. Neurosci Lett. 266:1999;217-219.
78. Yoshida N., Liberman M.C. Sound conditioning reduces noise-induced permanent threshold shift in mice. Hear Res. 148:2000;213-219.
79. Lim H.H., Jenkins O.H., Myers M.W., Miller J.M., Altschuler R.A. Detection of HSP 72 synthesis after acoustic overstimulation in rat cochlea. Hear Res. 69:1993;146-150.
80. Yoshida N., Kristiansen A., Liberman M.C. Heat stress and protection from permanent acoustic injury in mice. J Neurosci. 19:1999;10116-10124.
81. Keithley E.M., Ma C.L., Ryan A.F., Louis J.C., Magal E. GDNF protects the cochlea against noise damage. Neuroreport. 9:1998;2183-2187.
82. Shoji F., Yamasoba T., Magal E., Dolan D.F., Altschuler R.A., Miller J.M. Glial cell line-derived neurotrophic factor has a dose dependent influence on noise-induced hearing loss in the guinea pig cochlea. Hear Res. 142:2000;41-55.
83. Nam Y.J., Stover T., Hartman S.S., Altschuler R.A. Upregulation of glial cell line-derived neurotrophic factor (GDNF) in the rat cochlea following noise. Hear Res. 146:2000;1-6.
84. Shoji F., Miller A.L., Mitchell A., Yamasoba T., Altschuler R.A., Miller J.M. Differential protective effects of neurotrophins in the attenuation of noise-induced hair cell loss. Hear Res. 146:2000;134-142.
85. Gabaizadeh R., Staecker H., Liu W., Kopke R., Malgrange B., Lefebvre P.P., Van de Water T.R. Protection of both auditory hair cells and auditory neurons from cisplatin induced damage. Acta Otolaryngol. 117:1997;232-238.
86. Ernfors P., Duan M.L., ElShamy W.M., Canlon B. Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat Med. 2:1996;463-467.
87. Ohlemiller K.K., Wright J.S., Dugan L.L. Early elevation of cochlear reactive oxygen species following noise exposure. Audiol Neurootol. 4:1999;229-236.
88. Ohinata Y., Miller J.M., Altschuler R.A., Schacht J. Intense noise induces formation of vasoactive lipid peroxidation products in the cochlea. Brain Res. 878:2000;163-173.
89. Yamasoba T., Nuttall A.L., Harris C., Raphael Y., Miller J.M. Role of glutathione in protection against noise-induced hearing loss. Brain Res. 784:1998;82-90.
90. Yamasoba T., Schacht J., Shoji F., Miller J.M. Attenuation of cochlear damage from noise trauma by an iron chelator, a free radical scavenger and glial cell line-derived neurotrophic factor in vivo. Brain Res. 815:1999;317-325.
91. Morimoto R.I. Cells in stress, transcriptional activation of heat shock genes. Science. 259:1993;1409-1410.
92. Wadekar S.A., Li D., Periyasamy S., Sanchez E.R. Inhibition of heat shock transcription factor by GR. Mol Endocrinol. 15:2001;1396-1410.
93. Pratt W.B., Toft D.O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev. 18:1997;306-360.
94. Cheng B., Mattson M.P. NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res. 640:1994;56-67.
95. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci. 15:1995;1768-1777.
96. Cosi C., Spoerri P.E., Comelli M.C., Guidolin D., Skaper S.D. Glucocorticoids depress activity-dependent expression of BDNF mRNA in hippocampal neurones. Neuroreport. 4:1993;527-530.
97. McIntosh L.J., Sapolsky R.M. Glucocorticoids may enhance oxygen radical-mediated neurotoxicity. Neurotoxicology. 17:1996;873-882.
98. Calogero A.E., Gallucci W.T., Chrousos G.P., Gold P.W. Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro. J Clin Invest. 82:1988;839-846.
99. Irwin M., Hauger R., Brown M. Central corticotropin-releasing hormone activates the sympathetic nervous system and reduces immune function, increased responsivity of the aged rat. Endocrinology. 131:1992;1047-1053.
100. Swanson L.W., Sawchenko P.E. Hypothalamic integration, organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci. 6:1983;269-324.
101. Buijs R.M., Kalsbeek A. Hypothalamic integration of central and peripheral clocks. Nat Rev Neurosci. 2:2001;521-526.
102. Kvetnansky R., Fukuhara K., Pacak K., Cizza G., Goldstein D.S., Kopin I.J. Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats. Endocrinology. 133:1993;1411-1419.
103. Axelrod J., Reisine T.D. Stress hormones, their interaction and regulation. Science. 224:1984;452-459.
104. Pacak K., Armando I., Komoly S., Fukuhara K., Weise V.K., Holmes C., Kopin I.J., Goldstein D.S. Hypercortisolemia inhibits yohimbine-induced release of norepinephrine in the posterolateral hypothalamus of conscious rats. Endocrinology. 131:1992;1369-1376.
105. McMahon A., Kvetnansky R., Fukuhara K., Weise V.K., Kopin I.J., Sabban E.L. Regulation of tyrosine hydroxylase and dopamine beta-hydroxylase mRNA levels in rat adrenals by a single and repeated immobilization stress. J Neurochem. 58:1992;2124-2130.
106. Gianutsos G., Moore K.E. Effects of pre- or postnatal dexamethasone, adrenocorticotrophic hormone and environmental stress on phenylethanolamine N-methyltransferase activity and catecholamines in sympathetic ganglia of neonatal rats. J Neurochem. 28:1977;935-940.
107. Canlon B., Erichsen S., Nemlander E., Chen M., Celsi G., Ceccatelli S. Alterations in the intrauterine environment modifies the developmental programme of the auditory system. Eur J Neurosci. 17:2003;2035-2041.
108. Forrest D., Reh T.A., Rusch A. Neurodevelopmental control by thyroid hormone receptors. Curr Opin Neurobiol. 12:2002;49-56.
109. Uziel A., Legrand C., Rabie A. Corrective effects of thyroxine on cochlear abnormalities induced by congenital hypothyroidism in the rat. I. Morphological study. Brain Res. 351:1985;111-122.
110. Uziel A., Marot M., Rabie A. Corrective effects of thyroxine on cochlear abnormalities induced by congenital hypothyroidism in the rat. II. Electrophysiological study. Brain Res. 351:1985;123-127.
111. Knipper M., Zinn C., Maier H., Praetorius M., Rohbock K., Kopschall I., Zimmermann U. Thyroid hormone deficiency before the onset of hearing causes irreversible damage to peripheral and central auditory systems. J Neurophysiol. 83:2000;3101-3112.
112. Knipper M., Richardson G., Mack A., Muller M., Goodyear R., Limberger A., Rohbock K., Kopschall I., Zenner H.P., Zimmermann U. Thyroid hormone-deficient period prior to the onset of hearing is associated with reduced levels of beta-tectorin protein in the tectorial membrane, implication for hearing loss. J Biol Chem. 276:2001;39046-39052.
113. Bradley D.J., Towle H.C., Young W.S. 3rd. Alpha and beta thyroid hormone receptor (TR) gene expression during auditory neurogenesis, evidence for TR isoform-specific transcriptional regulation in vivo. Proc Natl Acad Sci USA. 91:1994;439-443.
114. Rusch A., Erway L.C., Oliver D., Vennstrom B., Forrest D. Thyroid hormone receptor beta-dependent expression of a potassium conductance in inner hair cells at the onset of hearing. Proc Natl Acad Sci USA. 95:1998;15758-15762.
115. Abel E.D., Boers M.E., Pazos-Moura C., Moura E., Kaulbach H., Zakaria M., Lowell B., Radovick S., Liberman M.C., Wondisford F. Divergent roles for thyroid hormone receptor beta isoforms in the endocrine axis and auditory system. J Clin Invest. 104:1999;291-300.
116. Rusch A., Ng L., Goodyear R., Oliver D., Lisoukov I., Vennstrom B., Richardson G., Kelley M.W., Forrest D. Retardation of cochlear maturation and impaired hair cell function caused by deletion of all known thyroid hormone receptors. J Neurosci. 21:2001;9792-9800.
117. Weber T., Zimmermann U., Winter H., Mack A., Kopschall I., Rohbock K., Zenner H.P., Knipper M. Thyroid hormone is a critical determinant for the regulation of the cochlear motor protein prestin. Proc Natl Acad Sci USA. 99:2002;2901-2906.
118. He D.Z., Jia S., Feng F. Thyroid hormone is not necessary for the development of outer hair cell electromotility. Hear Res. 175:2003;183-189.
119. Fukuhara K., Kvetnansky R., Cizza G., Pacak K., Ohara H., Goldstein D.S., Kopin I.J. Interrelations between sympathoadrenal system and hypothalamo-pituitary-adrenocortical/thyroid systems in rats exposed to cold stress. J Neuroendocrinol. 8:1996;533-541.
120. Drescher D.G. Effect of temperature on cochlear responses during and after exposure to noise. J Acoust Soc Am. 59:1976;401-407.
121. Henry K.R., Chole R.A. Hypothermia protects the cochlea from noise damage. Hear Res. 16:1984;225-230.
122. Viau V. Functional cross-talk between the hypothalamic-pituitary-gonadal and -adrenal axes. J Neuroendocrinol. 14:2002;506-513.
123. Andrews J.C., Ator G.A., Honrubia V. The exacerbation of symptoms in Meniere's disease during the premenstrual period. Arch Otolaryngol Head Neck Surg. 118:1992;74-78.
124. Swanson S.J., Dengerink H.A. Changes in pure-tone thresholds and temporary threshold shifts as a function of menstrual cycle and oral contraceptives. J Speech Hear Res. 31:1988;569-574.
125. Darlington C.L., Ross A., King J., Smith P.F. Menstrual cycle effects on postural stability but not optokinetic function. Neurosci Lett. 307:2001;147-150.
126. Nathan C.A., Kim T.S., Harris J.P., Koutnouyan H.A., Ryan A.F. Absence of mRNA encoding estrogen receptor in the rat cochlea. Acta Otolaryngol. 119:1999;853-857.
127. Stenberg A.E., Wang H., Sahlin L., Hultcrantz M. Mapping of estrogen receptors alpha and beta in the inner ear of mouse and rat. Hear Res. 136:1999;29-34.
128. Stenberg A.E., Wang H., Fish J. 3rd, Schrott-Fischer A., Sahlin L., Hultcrantz M. Estrogen receptors in the normal adult and developing human inner ear and in Turner's syndrome. Hear Res. 157:2001;87-92.
129. Lee J.H., Marcus D.C. Estrogen acutely inhibits ion transport by isolated stria vascularis. Hear Res. 158:2001;123-130.
130. Gregerson K.A., Selmanoff M. Selective effects of hyperprolactinemia on in vitro dopamine release from median eminence synaptosomes. J Neurosci. 8:1988;2477-2484.
131. Foord S.M., Peters J.R., Dieguez C., Scanlon M.F., Hall R. Dopamine receptors on intact anterior pituitary cells in culture, functional association with the inhibition of prolactin and thyrotropin. Endocrinology. 112:1983;1567-1577.
132. Bole-Feysot C., Goffin V., Edery M., Binart N., Kelly P.A. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev. 19:1998;225-268.
133. Freeman M.E., Kanyicska B., Lerant A., Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev. 80:2000;1523-1631.
134. Leite De Moraes M.C., Touraine P., Gagnerault M.C., Savino W., Kelly P.A., Dardenne M. Prolactin receptors and the immune system. Ann Endocrinol. 56:1995;567-570.
135. Royster M., Driscoll P., Kelly P.A., Freemark M. The prolactin receptor in the fetal rat, cellular localization of messenger ribonucleic acid, immunoreactive protein, and ligand-binding activity and induction of expression in late gestation. Endocrinology. 136:1995;3892-3900.
136. Pippard C., Baylis P.H. Prolactin stimulates Na+-K+-ATPase activity located in the outer renal medulla of the rat. J Endocrinol. 108:1986;95-99.
137. Horner K.C., Guieu R., Magnan J., Chays A., Cazals Y. Prolactinoma in some Meniere's patients - is stress involved? Neuropsychopharmacology. 26:2002;135-138.
138. Biller B.M., Luciano A., Crosignani P.G., Molitch M., Olive D., Rebar R., Sanfilippo J., Webster J., Zacur H. Guidelines for the diagnosis and treatment of hyperprolactinemia. J Reprod Med. 44:1999;1075-1084.
139. Boiko N.V., Kolmakova T.S., Nesterenko E.N., Groisberg F. Characteristics of prolactin secretion in response to different degrees of lesions of the vestibular analyzer. Kosm Biol Aviakosm Med. 25:1991;46-48.
140. Petrosini L., Dell'Anna M.E. Vestibular compensation is affected by treatment with dopamine active agents. Arch Ital Biol. 131:1993;159-171.
141. Drago F., Nardo L., Rampello L., Raffaele R. Vestibular compensation in aged rats with unilateral labyrinthectomy treated with dopaminergic drugs. Pharmacol Res. 33:1996;135-140.
142. Nelson W.O. Some effects of hypophyseal tumors induced by treatment with estrogens [abstract]. Cancer Res. 2:1942;728.
143. Xu R.K., Wu X.M., Di A.K., Xu J.N., Pang C.S., Pang S.F. Pituitary prolactin-secreting tumor formation, recent developments. Biol Signals Recept. 9:2000;1-20.
144. Piroli G., Grillo C., Ferrini M., Diaz-Torga G., Libertun C., De Nicola A.F. Restoration by bromocriptine of glucocorticoid receptors and glucocorticoid negative feedback on prolactin secretion in estrogen-induced pituitary tumors. Neuroendocrinology. 58:1993;273-279.
145. Duskova J., Schreiber V. Nucleolar inhibition in prolactin cells after combined thyroid hormone plus lisuride treatment in estrogenized rats. Endocrinol Exp. 23:1989;185-194.
146. Nedvidkova J., Pacak K., Nedvidek J., Goldstein D.S., Schreiber V. Triiodothyronine attenuates estradiol-induced increases in dopamine D-2 receptor number in rat anterior pituitary. Brain Res. 712:1996;148-152.
147. DePaolo L.V., Berardo P.V., Carrillo A.J. Intraventricular administration of arginine vasopressin suppresses prolactin release via a dopaminergic mechanism. Peptides. 7:1986;541-544.
148. Furuta H., Luo L., Ryan A.F., Mori N. Expression of mRNA encoding vasopressin V1a, vasopressin V2, and ANP-B receptors in the rat cochlea. Hear Res. 117:1998;140-148.
149. Kitano H., Takeda T., Suzuki M., Kitanishi T., Yazawa Y., Kitajima K., Kimura H., Tooyama I. Vasopressin and oxytocin receptor mRNAs are expressed in the rat inner ear. Neuroreport. 8:1997;2289-2292.
150. Zenner H.P., Zenner B. Vasopressin and isoproterenol activate adenylate cyclase in the guinea pig inner ear. Arch Otorhinolaryngol. 222:1979;275-283.
151. Schacht J. Hormonal regulation of adenylate cyclase in the stria vascularis of the mouse. Hear Res. 20:1985;9-13.
152. Takeda T., Takeda S., Kitano H., Okada T., Kakigi A. Endolymphatic hydrops induced by chronic administration of vasopressin. Hear Res. 140:2000;1-6.
153. Mori N., Shugyo A., Asai H. The effect of arginine-vasopressin and its analogues upon the endocochlear potential in the guinea pig. Acta Otolaryngol. 107:1989;80-84.
154. Mhatre A.N., Jero J., Chiappini I., Bolasco G., Barbara M., Lalwani A.K. Aquaporin-2 expression in the mammalian cochlea and investigation of its role in Meniere's disease. Hear Res. 170:2002;59-69.
155. Kumagami H., Loewenheim H., Beitz E., Wild K., Schwartz H., Yamashita K., Schultz J., Paysan J., Zenner H.P., Ruppersberg J.P. The effect of anti-diuretic hormone on the endolymphatic sac of the inner ear. Pflugers Arch. 436:1998;970-975.
156. Yamakawa K. Uber die pathologische Veranderung bei einem Menière-Kranken. J Otolaryngol Jpn. 44:1938;2310-2312.
157. Hallpike C.S., Cairns H. Observations on the pathology of Ménière's syndrome. Proc R Soc Med. 31:1938;1317-1331.
158. Takeda T., Kakigi A., Saito H. Antidiuretic hormone (ADH) and endolymphatic hydrops. Acta Otolaryngol Suppl. 519:1995;219-222.
159. Sawada S., Takeda T., Saito H. Antidiuretic hormone and psychosomatic aspects in Meniere's disease. Acta Otolaryngol Suppl. 528:1997;109-112.
160. Dugue B., Leppanen E.A., Teppo A.M., Fyhrquist F., Grasbeck R. Effects of psychological stress on plasma interleukins-1 beta and 6, C-reactive protein, tumour necrosis factor alpha, anti-diuretic hormone and serum cortisol. Scand J Clin Lab Invest. 53:1993;555-561.
161. Rybak L.P. Metabolic disorders of the vestibular system. Otolaryngol Head Neck Surg. 112:1995;128-132.
162. Tekin M., Arnos K.S., Pandya A. Advances in hereditary deafness. Lancet. 358:2001;1082-1090.
163. Petit C., Levilliers J., Hardelin J.P. Molecular genetics of hearing loss. Annu Rev Genet. 35:2001;589-646.
164. Losel R., Wehling M. Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol. 4:2003;46-55.
165. Borg E. Individual varibility of noise-induced hearing loss. Dancer A.L., Henderson D., Salvi R.J., Hamernik R.P. Mosby-year book. 1992;467-475 Mosby, St Louis, MO.
166. Kofman O. The role of prenatal stress in the etiology of developmental behavioural disorders. Neurosci Biobehav Rev. 26:2002;457-470.